(Date:12/11/2009)... -- Algeta ASA (OSE: ALGETA), the,cancer therapeutics ... in the,US, the Tulane Cancer Center, New ... III clinical study of Alpharadin in men ... that has metastasized to the skeleton. , ... in SYMptomatic Prostate CAncer) study is a,double-blind, ...
(Date:12/10/2009)... Corporation (Nasdaq: DNDN ) announced today that it ... of its common stock at a price to the ... to the underwriters a 30-day option to purchase up ... cover overallotments, if any. The offering is expected ... closing conditions. ,, J. P. Morgan Securities Inc. and ...
(Date:12/10/2009)... NEWCASTLE, United Kingdom, Dec. 10 ... North East England Stem Cell Institute (NESCI) ... first successful treatment of eight patients with ... patients, own stem cells without the need ... http://www.newscom.com/cgi-bin/prnh/20080422/CLTU133LOGO-a ) ,, LSCD is a ...
(Date:12/10/2009)... Pharmaceuticals, Inc.,(OTC Bulletin Board: LTUS) ("Lotus" or ... prescription drugs and licensed national seller of ... ("PRC"), today reported that,effective December 1, 2009, ... Lotus,appointed Mr. Jinzhong HAN to be General ... Division"). , Mr. ...
Breaking Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3... to Approve Merger With Integra on October 11, ... ... California, September 5 IsoTis, Inc.,(NASDAQ: ISOT ) ("IsoTis"), an ... the U.S. Securities and,Exchange Commission ("SEC") in connection with the IsoTis-Integra,LifeSciences ...
... Sept. 5 Pressure,BioSciences, Inc. (Nasdaq: PBIO ... CE Mark the Barocycler NEP2320, a patent-pending, lightweight,compressed ... also announced that it has been issued a ... Barocycler NEP2320 has been found in,compliance with the ...
... Inc. (NYSE: TMO ), the world leader ... of Davis Inotek Instruments, LLC.,The acquired business will ... services. Davis Instruments is a leading provider of,test, ... a,wide range of industries through its extensive catalog ...
Other Biology Technology:IsoTis Files Definitive Proxy Statement 2IsoTis Files Definitive Proxy Statement 3IsoTis Files Definitive Proxy Statement 4Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320 2Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320 3Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320 4Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek 2Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek 3Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek 4... cocktail is tailored to efficiently ... suspensions of non-human primate (Rhesus ... using the StemSep (or compatible ... system, achieving a 2.6 Log ...
...
...
... Agarose was developed specifically for pulsed field separations of DNA larger than 2, ... megabase pairs. This agarose has the ... ... done in Chromosomal Grade, ...
Biology Products:Biology NavigationMedical Navigation